Smith and Nephew (Prudoxin product) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Smith and Nephew (Prudoxin product) General Information

Description

Medicine used to treat depression, anxiety disorders and insomnia. The Prudoxin product is used for the treatment of chronic idiopathic urticaria (hives).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Delcor Asset
Primary Office
  • London
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Smith and Nephew (Prudoxin product) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Smith and Nephew (Prudoxin product)‘s full profile, request access.

Request a free trial

Smith and Nephew (Prudoxin product) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Smith and Nephew (Prudoxin product)‘s full profile, request access.

Request a free trial